Ann Rheum Dis

Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.

Kearsley-Fleet L, Chang ML, Lawson-Tovey S, ..., Natter M, Hyrich KL

Ann Rheum Dis - (-) - [2022-03-25; online 2022-03-25]

Category: Health Type: Journal article

Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?

Bower H, Frisell T, Di Giuseppe D, Delcoigne B, Askling J

Ann Rheum Dis - (-) - [2021-11-22; online 2021-11-22]

Category: Health Type: Journal article

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

Strangfeld A, Schäfer M, Gianfrancesco MA, ..., Machado PM, COVID-19 Global Rheumatology Alliance

Ann Rheum Dis 80 (7) 930-942 [2021-07-00; online 2021-01-27]

Category: Health Type: Journal article

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.

Sparks JA, Wallace ZS, Seet AM, ..., Yazdany J, COVID-19 Global Rheumatology Alliance

Ann Rheum Dis - (-) - [2021-05-28; online 2021-05-28]

Category: Health Type: Journal article

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study.

Bower H, Frisell T, Di Giuseppe D, ..., Askling J, ARTIS Study Group

Ann Rheum Dis - (-) - [2021-02-23; online 2021-02-23]

Category: Public Health Type: Journal article

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist.

Graef ER, Liew JW, Putman MS, ..., Sparks JA, COVID-19 Global Rheumatology Alliance

Ann Rheum Dis 79 (6) 734-736 [2020-06-00; online 2020-04-15]

Type: Review